ProText Mobility Inc (TXTM)

[Cimba]

Very interesting:


On September 20, 2016, the Company’s Board of Directors voted to approve a stock dividend of 25 million shares, representing 25% of the total outstanding stock of its wholly-owned subsidiary, Cannabis Biosciences, Inc., which will be paid to Plandaí’s shareholders of record as of September 30, 2016. The Company intends to file a registration statement covering the dividend shares as part of the Company’s plan to spin Cannabis Biosciences off as a separate, publicly-traded entity in the coming months.

Cannabis Biosciences is the parent company of Plandaí Biotechnology Uruguay, S.A., and holds the license from Plandaí to conduct all product development, clinical trials, sales and marketing for Plandaí’s cannabis-derived bioavailable extract.

Who owns the shares for Pladai Bio Uruguay?